Keyphrases
Denmark
91%
Hepatitis C Virus
71%
HIV Patients
62%
COVID-19
51%
People Living with HIV (PLHIV)
49%
Confidence Interval
49%
AIDS/HIV
36%
National Cohort Study
34%
Human Immunodeficiency Virus Type 1 (HIV-1)
31%
Antiretroviral Therapy
28%
HIV Infection
25%
Virus
24%
Risk Factors
22%
Highly Active Antiretroviral Therapy (HAART)
22%
Hepatitis C Virus Genotypes
21%
Comorbidity
20%
CD4 Count
16%
Infected Patients
16%
Incidence Rate
16%
Copenhagen
15%
Genotype 1
15%
Chronic Hepatitis C
15%
Infected Individual
14%
Recombinant
14%
Staphylococcus Aureus Bacteremia
14%
Genotype
13%
Europe
13%
Hepatitis C Virus Infection
13%
Neutralizing Antibodies
12%
Community-acquired Pneumonia
12%
Refugees
12%
Randomized Controlled Trial
12%
JFH1
11%
Odds Ratio
11%
Hepatitis C
10%
Tuberculosis
10%
Migrants
10%
Protease Inhibitors
10%
Combined Antiretroviral Therapy (cART)
10%
Immigrants
9%
Prospective Cohort Study
9%
Cell Culture Model
8%
Hazard Ratio
8%
Hospitalization
8%
Genotype 3
8%
Infectious Diseases
8%
Invasive Pneumococcal Disease
8%
Human Immunodeficiency Virus Infection
7%
High Risk
7%
Matched Cohort Study
7%
Non-associated
7%
Diabetes
7%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
7%
Mortality Rate
7%
Direct-acting Antivirals
7%
Viral Load
7%
Meningitis
7%
Register Study
7%
Patients with COVID-19
7%
Hospitalized Patients
6%
Cell Culture
6%
Placebo
6%
Cirrhosis
6%
Vaccination
6%
Meta-analysis
6%
Ribavirin
6%
Hypervariable Region
6%
Myocardial Infarction
6%
Cardiovascular Risk
6%
Population-based Cohort Study
6%
HIV-positive
6%
Clinical Outcomes
6%
Relative Risk
6%
Mycobacterium Tuberculosis (M. tb)
6%
Adjusted Odds Ratio
5%
NS5A
5%
Hepatitis C Virus RNA
5%
Bacteremia
5%
Polymorphism
5%
Observational Cohort Study
5%
Risk of Death
5%
Retrospective Cohort Study
5%
EuroSIDA
5%
Virological Failure
5%
CD8+ T Cells
5%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
5%
Genotype 2a
5%
Hepatocellular Carcinoma
5%
Sweden
5%
Nationwide Registers
5%
Hepatitis B Virus
5%
Sustained Virological Response
5%
Randomized Trial
5%
Healthcare Workers
5%
Interleukin-6
5%
Tumor Necrosis Factor-α
5%
Cardiovascular Disease
5%
Viral Replication
5%
Epitope
5%
HIV RNA
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Cohort Analysis
47%
Infection
43%
COVID-19
29%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Disease
19%
Prevalence
18%
Hepatitis C Virus
17%
Human Immunodeficiency Virus Infection
16%
Antiretroviral Therapy
14%
Symptom
13%
Chronic Hepatitis C
12%
Odds Ratio
11%
Community-Acquired Pneumonia
10%
Population
10%
Randomized Controlled Trial
9%
Hazard Ratio
9%
Malignant Neoplasm
8%
Hepatitis C
8%
Prospective Cohort Study
8%
Highly Active Antiretroviral Therapy
7%
Diabetes
7%
Antivirus Agent
7%
Diagnosis
7%
Cross Sectional Study
7%
Systematic Review
7%
Staphylococcal Bacteremia
7%
Mortality Rate
6%
Biological Marker
5%
Logistic Regression Analysis
5%
Placebo
5%
Cell Count
5%
Liver Cirrhosis
5%
Immigrant
5%
Antibiotics
5%
Serotype
5%
Cardiovascular Disease
5%